ctrl K

AI Score

Unlock

BioXcel Therapeutics Inc. (BTAI)

AI Score

Unlock

3.81

1.65 (76.39%)

At close: Mar 03, 2025, 3:59 PM

3.55

-6.82%

After-hours: Mar 03, 2025, 07:49 PM EST

BioXcel Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Revenue	1.38M	375K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.26M	20K	297K	188K	156K	17K	1K	n/a	n/a
Gross Profit	120K	355K	-297K	-188K	-156K	-17K	-1K	n/a	n/a
Operating Income	-171.78M	-159.65M	-106.94M	-82.3M	-33.6M	-19.96M	-4.54M	-2.12M	-636K
Interest Income	5.65M	2.53M	4K	155K	633K	n/a	n/a	n/a	n/a
Pretax Income	-179.05M	-165.76M	-106.93M	-82.17M	-32.97M	-19.27M	-4.54M	-2.12M	-636K
Net Income	-179.05M	-171.85M	-106.63M	-82.01M	-32.34M	-19.27M	-4.54M	-2.12M	-636K
Selling & General & Admin	83.41M	68.76M	54.23M	24.3M	7.8M	5.4M	1.85M	721K	403K
Research & Development	84.33M	91.24M	52.71M	57.99M	25.8M	14.56M	2.69M	1.4M	233K
Other Expenses	4.16M	-427K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	171.9M	160M	106.94M	82.3M	33.6M	19.96M	4.54M	2.12M	636K
Interest Expense	13.31M	8.21M	40K	27K	n/a	n/a	2K	n/a	n/a
Selling & Marketing Expenses	19.9M	13.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	173.16M	160.02M	106.94M	82.3M	33.6M	19.96M	4.54M	2.12M	636K
Income Tax	n/a	6.09M	-301K	-161K	-633K	692K	n/a	-2.12M	n/a
Shares Outstanding (Basic)	29.13M	28.02M	26.37M	21.68M	16.29M	14.57M	15.19M	15.65M	15.94M
Shares Outstanding (Diluted)	29.13M	28.02M	26.37M	21.68M	16.29M	14.57M	15.19M	15.65M	15.94M
EPS (Basic)	-6.15	-6.13	-4.04	-3.78	-1.99	-1.32	-0.3	-0.14	-0.04
EPS (Diluted)	-6.15	-6.13	-4.04	-3.78	-1.99	-1.32	-0.3	-0.14	-0.04
EBITDA	-165.42M	-157.38M	-107M	-81.98M	-32.81M	-19.25M	-4.54M	n/a	-636K
Depreciation & Amortization	318K	327K	297K	188K	156K	17K	1K	2.12M	n/a